Stem Cell
Hope Biosciences Receives FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19
The FDA has approved a Phase II clinical trial evaluating efficacy and safety of the Hope Bioscience autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) to provide immune support against COVID-19.
